Study: Cancer survival rates not linked to Medicare spending

03/13/2013 | HealthDay News · Medscape (free registration)

Medicare data show average spending on patients with advanced lung, colorectal, pancreas, breast and prostate cancers varied by up to 41% across U.S. regions but had no direct effect on survival, researchers reported in the Journal of the National Cancer Institute. The study should be analyzed to see whether patients had access to palliative and hospice care, said American Cancer Society Vice President Elizabeth Ward. "Palliative care can apply throughout the entire course of the disease," Ward said. "When patients have reached the point when the physicians say that there is no treatment available, then there is a range of options for them."

View Full Article in:

HealthDay News · Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA